N4-phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease.

Source:http://linkedlifedata.com/resource/pubmed/id/17827006

Bioorg. Med. Chem. Lett. 2007 Nov 1 17 21 5783-9

Download in:

View as

General Info

PMID
17827006